{"id":77374,"date":"2016-11-11T11:40:00","date_gmt":"2016-11-11T11:40:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/"},"modified":"2016-11-11T11:40:00","modified_gmt":"2016-11-11T11:40:00","slug":"els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/","title":{"rendered":"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis"},"content":{"rendered":"<p>\u00a0<\/p>\n<ul>\n<li><strong><span>En el marc del Dia Mundial participen en diferents activitats per debatre entorn aquesta malaltia i oferir consell farmac\u00e8utic<\/span><\/strong><\/li>\n<li><strong>Aquests professionals sanitaris desenvolupen un paper clau en el seguiment del pacient amb diabetis i en l\u2019optimitzaci\u00f3 del tractament\u00a0<\/strong><b>\n<\/p>\n<p><\/b><\/li>\n<\/ul>\n<p><i>Barcelona, 11 de novembre de 2016.- <\/i><span>El proper <\/span><b>14 de novembre<\/b><span> se celebra el <\/span><b>Dia Mundial de la Diabetis<\/b><span>, una malaltia que, segons preveu l\u2019Organitzaci\u00f3 Mundial de Salut, al 2030 ser\u00e0 la setena causa de mortalitat. En el marc d\u2019aquesta efem\u00e8ride, que enguany se celebra sota el <\/span><b>lema \u201cObre els ulls a la diabetis\u201d, els farmac\u00e8utics de Barcelona s\u2019han implicat en diferents activitats amb l\u2019objectiu de contribuir a millorar la seva prevenci\u00f3, el seu control i la informaci\u00f3 que es t\u00e9 sobre els tractaments.<\/b><br \/><b><u><br \/>12 de novembre, consell farmac\u00e8utic a la Jornada de l\u2019Associaci\u00f3 de Diab\u00e8tics de Catalunya <\/p>\n<p><\/u><\/b><\/p>\n<p class=\"MsoNormal\">L\u2019Associaci\u00f3 de Diab\u00e8tics de Catalunya, en col\u00b7laboraci\u00f3 amb diferents entitats i institucions, entre elles el Col\u00b7legi de Farmac\u00e8utics de Barcelona, ha organitzat el proper <b>12 de novembre una jornada entorn la diabetis a la Pla\u00e7a Universitat de Barcelona. <\/b>Un dels actes programats \u00e9s l\u2019anomenat <b>\u201cEscolta els consells del teu farmac\u00e8utic\u201d, en el qual un farmac\u00e8utic oferir\u00e0 sessions sobre l\u2019\u00fas dels f\u00e0rmacs en pacients amb diabetis. <\/b><\/p>\n<p class=\"MsoNormal\"><b><u>Estrat\u00e8gies de prevenci\u00f3, control i tractament en la diabetis<\/p>\n<p><\/u><\/b><\/p>\n<p class=\"MsoNormal\">Amb l\u2019objectiu de plantejar una actuaci\u00f3 assistencial multidisciplin\u00e0ria i integral del pacient diab\u00e8tic tipus 2, basada en estrat\u00e8gies d\u2019actuaci\u00f3 dissenyades per prevenir la malaltia, el control dels factors de risc cardiovascular i en la valoraci\u00f3 cl\u00ednica i en el seguiment farmacoterap\u00e8utic,<b> un centenar de<span> <\/span>farmac\u00e8utics van participar ahir a l\u2019activitat \u201cEstrat\u00e8gies de prevenci\u00f3, control i tractament en la diabetis mellitus tipus 2\u201d. <\/b><\/p>\n<p class=\"MsoNormal\">Organitzada pel Col\u00b7legi de Farmac\u00e8utics de Barcelona, en col\u00b7laboraci\u00f3 amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica i la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria, i patrocinada per AstraZeneca, diferents especialistes <b>van reflexionar conjuntament sobre temes com quina \u00e9s la visi\u00f3 des de la salut p\u00fablica, l\u2019evid\u00e8ncia dels nous f\u00e0rmacs antidiab\u00e8tics i qu\u00e8 es pot fer per millorar la qualitat de vida dels pacients.<\/b> Al final de la jornada, tamb\u00e9 hi va haver un debat amb els assistents dels punts clau exposats.<b><span lang=\"ES\"><\/p>\n<p><\/span><\/b><\/p>\n<p class=\"MsoNormal\"><b><u>Qu\u00e8 pot aportar el farmac\u00e8utic en la diabetis? <\/p>\n<p><\/u><\/b><\/p>\n<p class=\"MsoNormal\"><b>El farmac\u00e8utic t\u00e9 un paper clau en la diabetis, doncs un cop ja s\u2019ha diagnosticat la malaltia, pot realitzar proves de gluc\u00e8mia <\/b>al pacient per fer-li el control i comprovar si els nivells de sucre estan estabilitzats. D\u2019altra banda, tamb\u00e9 t\u00e9 un paper rellevant en el <b>seguiment farmacoterap\u00e8utic del pacient diab\u00e8tic, sobretot el tipus 2 tractat amb antidiab\u00e8tics orals,<\/b> ja que, molt sovint, t\u00e9 patologies associades amb el seu tractament corresponent. <\/p>\n<p class=\"MsoNormal\">Alhora, des de la farm\u00e0cia es pot aconsellar als pacients sobre <b>com optimitzar els tractaments <\/b>\u00a0i <b>posar l\u2019\u00e8mfasi en la prevenci\u00f3<\/b> recomanant, entre d\u2019altres aspectes, dur una dieta adequada baixa en sal i greixos, controlar els carbohidrats, menjar m\u00e9s pollastre que carns vermelles i mantenir un pes adequat. <\/p>\n<p class=\"MsoNormal\">M\u00e9s informaci\u00f3 sobre la diabetis al web de salut del COFB<a href=\"http:\/\/www.farmaceuticonline.com\/ca\/component\/content\/article\/2-catfamilia\/590-diabetes\"> Farmaceuticonline\u00a0<\/a><\/p>\n<p class=\"MsoNormal\"><b><br \/>Per a m\u00e9s informaci\u00f3: <\/p>\n<p><\/b><\/p>\n<p class=\"MsoNormal\">Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/p>\n<p class=\"MsoNormal\">Tel\u00e8fon: 93 244 07 28 \/ 18 <\/p>\n<p class=\"MsoNormal\"><a href=\"mailto:premsa@cofb.net\">premsa@cofb.net<\/a> <\/p>\n<p class=\"MsoNormal\">\n<p>\u00a0En el marc del Dia Mundial participen en diferents activitats per debatre entorn aquesta malaltia i oferir consell farmac\u00e8uticAquests professionals sanitaris desenvolupen un paper clau en el seguiment del pacient amb diabetis i en l\u2019optimitzaci\u00f3 del tractament\u00a0Barcelona, 11 de novembre de 2016.- El proper 14 de novembre se celebra el Dia Mundial de la Diabetis, una malaltia que, segons preveu l\u2019Organitzaci\u00f3 Mundial de Salut, al 2030 ser\u00e0 la setena causa de mortalitat. En el marc d\u2019aquesta efem\u00e8ride, que enguany se celebra sota el lema \u201cObre els ulls a la diabetis\u201d, els farmac\u00e8utics de Barcelona s\u2019han implicat en diferents activitats amb l\u2019objectiu de contribuir a millorar la seva prevenci\u00f3, el seu control i la informaci\u00f3 que es t\u00e9 sobre els tractaments.12 de novembre, consell farmac\u00e8utic a la Jornada de l\u2019Associaci\u00f3 de Diab\u00e8tics de Catalunya   L\u2019Associaci\u00f3 de Diab\u00e8tics de Catalunya, en col\u00b7laboraci\u00f3 amb diferents entitats i institucions, entre elles el Col\u00b7legi de Farmac\u00e8utics de Barcelona, ha organitzat el proper 12 de novembre una jornada entorn la diabetis a la Pla\u00e7a Universitat de Barcelona. Un dels actes programats \u00e9s l\u2019anomenat \u201cEscolta els consells del teu farmac\u00e8utic\u201d, en el qual un farmac\u00e8utic oferir\u00e0 sessions sobre l\u2019\u00fas dels f\u00e0rmacs en pacients amb diabetis.   Estrat\u00e8gies de prevenci\u00f3, control i tractament en la diabetis  Amb l\u2019objectiu de plantejar una actuaci\u00f3 assistencial multidisciplin\u00e0ria i integral del pacient diab\u00e8tic tipus 2, basada en estrat\u00e8gies d\u2019actuaci\u00f3 dissenyades per prevenir la malaltia, el control dels factors de risc cardiovascular i en la valoraci\u00f3 cl\u00ednica i en el seguiment farmacoterap\u00e8utic, un centenar de farmac\u00e8utics van participar ahir a l\u2019activitat \u201cEstrat\u00e8gies de prevenci\u00f3, control i tractament en la diabetis mellitus tipus 2\u201d.   Organitzada pel Col\u00b7legi de Farmac\u00e8utics de Barcelona, en col\u00b7laboraci\u00f3 amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica i la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria, i patrocinada per AstraZeneca, diferents especialistes van reflexionar conjuntament sobre temes com quina \u00e9s la visi\u00f3 des de la salut p\u00fablica, l\u2019evid\u00e8ncia dels nous f\u00e0rmacs antidiab\u00e8tics i qu\u00e8 es pot fer per millorar la qualitat de vida dels pacients. Al final de la jornada, tamb\u00e9 hi va haver un debat amb els assistents dels punts clau exposats.  Qu\u00e8 pot aportar el farmac\u00e8utic en la diabetis?   El farmac\u00e8utic t\u00e9 un paper clau en la diabetis, doncs un cop ja s\u2019ha diagnosticat la malaltia, pot realitzar proves de gluc\u00e8mia al pacient per fer-li el control i comprovar si els nivells de sucre estan estabilitzats. D\u2019altra banda, tamb\u00e9 t\u00e9 un paper rellevant en el seguiment farmacoterap\u00e8utic del pacient diab\u00e8tic, sobretot el tipus 2 tractat amb antidiab\u00e8tics orals, ja que, molt sovint, t\u00e9 patologies associades amb el seu tractament corresponent.   Alhora, des de la farm\u00e0cia es pot aconsellar als pacients sobre com optimitzar els tractaments \u00a0i posar l\u2019\u00e8mfasi en la prevenci\u00f3 recomanant, entre d\u2019altres aspectes, dur una dieta adequada baixa en sal i greixos, controlar els carbohidrats, menjar m\u00e9s pollastre que carns vermelles i mantenir un pes adequat.   M\u00e9s informaci\u00f3 sobre la diabetis al web de salut del COFB Farmaceuticonline\u00a0Per a m\u00e9s informaci\u00f3: Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)Tel\u00e8fon: 93 244 07 28 \/ 18 premsa@cofb.net\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 En el marc del Dia Mundial participen en diferents activitats per debatre entorn aquesta malaltia i oferir consell farmac\u00e8utic Aquests professionals sanitaris desenvolupen un paper clau en el seguiment del pacient amb diabetis i en l\u2019optimitzaci\u00f3 del tractament\u00a0 Barcelona, 11 de novembre de 2016.- El proper 14 de novembre [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77374","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 En el marc del Dia Mundial participen en diferents activitats per debatre entorn aquesta malaltia i oferir consell farmac\u00e8utic Aquests professionals sanitaris desenvolupen un paper clau en el seguiment del pacient amb diabetis i en l\u2019optimitzaci\u00f3 del tractament\u00a0 Barcelona, 11 de novembre de 2016.- El proper 14 de novembre [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-11T11:40:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis\",\"datePublished\":\"2016-11-11T11:40:00+00:00\",\"dateModified\":\"2016-11-11T11:40:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\"},\"wordCount\":1150,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\",\"name\":\"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2016-11-11T11:40:00+00:00\",\"dateModified\":\"2016-11-11T11:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/","og_locale":"ca_ES","og_type":"article","og_title":"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 En el marc del Dia Mundial participen en diferents activitats per debatre entorn aquesta malaltia i oferir consell farmac\u00e8utic Aquests professionals sanitaris desenvolupen un paper clau en el seguiment del pacient amb diabetis i en l\u2019optimitzaci\u00f3 del tractament\u00a0 Barcelona, 11 de novembre de 2016.- El proper 14 de novembre [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-11-11T11:40:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis","datePublished":"2016-11-11T11:40:00+00:00","dateModified":"2016-11-11T11:40:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/"},"wordCount":1150,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/","url":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/","name":"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2016-11-11T11:40:00+00:00","dateModified":"2016-11-11T11:40:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/11\/11\/els-farmaceutics-de-barcelona-implicats-en-la-prevencio-el-control-i-el-tractament-de-la-diabetis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Els farmac\u00e8utics de Barcelona, implicats en la prevenci\u00f3, el control i el tractament de la diabetis"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 En el marc del Dia Mundial participen en diferents activitats per debatre entorn aquesta malaltia i oferir consell farmac\u00e8utic Aquests professionals sanitaris desenvolupen un paper clau en el seguiment del pacient amb diabetis i en l\u2019optimitzaci\u00f3 del tractament\u00a0 Barcelona, 11 de novembre de 2016.- El proper 14 de novembre [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77374"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77374\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}